Aurora Cannabis (NASDAQ:ACB) Upgraded to Strong-Buy at TD Securities

TD Securities upgraded shares of Aurora Cannabis (NASDAQ:ACB) to a strong-buy rating in a research note published on Thursday,Zacks.com reports.

Separately, TD Cowen assumed coverage on Aurora Cannabis in a research report on Wednesday. They set a “buy” rating for the company.

Aurora Cannabis Price Performance

ACB stock opened at $4.27 on Thursday. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. The stock has a market cap of $234.18 million, a PE ratio of -5.62 and a beta of 1.86. Aurora Cannabis has a 1 year low of $2.84 and a 1 year high of $9.35. The stock has a 50-day moving average price of $5.02 and a two-hundred day moving average price of $5.55.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC bought a new stake in shares of Aurora Cannabis during the 2nd quarter valued at $50,000. Cetera Advisors LLC acquired a new position in Aurora Cannabis during the first quarter worth about $59,000. Toronto Dominion Bank increased its position in Aurora Cannabis by 34,356.4% during the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock worth $88,000 after purchasing an additional 18,896 shares in the last quarter. Mackenzie Financial Corp bought a new stake in shares of Aurora Cannabis during the second quarter worth $113,000. Finally, TD Asset Management Inc bought a new stake in Aurora Cannabis during the 2nd quarter worth $255,000. 47.63% of the stock is owned by institutional investors and hedge funds.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.